Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Third Tysabri adverse case hits drug class.

× No keyword cloud information.

5 in total

1. A small molecule that inhibits the interaction of paxillin and alpha 4 integrin inhibits accumulation of mononuclear leukocytes at a site of inflammation.

Authors: Christiane Kummer; Brian G Petrich; David M Rose; Mark H Ginsberg
Journal: J Biol Chem Date: 2010-01-22 Impact factor: 5.157

Review 2. RNAi-based therapeutic strategies for metabolic disease.

Authors: Michael P Czech; Myriam Aouadi; Gregory J Tesz
Journal: Nat Rev Endocrinol Date: 2011-04-19 Impact factor: 43.330

Review 3. Why can't we find a new treatment for SLE?

Authors: Robert Eisenberg
Journal: J Autoimmun Date: 2009-03-28 Impact factor: 7.094

4. Blocking the alpha 4 integrin-paxillin interaction selectively impairs mononuclear leukocyte recruitment to an inflammatory site.

Authors: Chloé C Féral; David M Rose; Jaewon Han; Norma Fox; Gregg J Silverman; Kenneth Kaushansky; Mark H Ginsberg
Journal: J Clin Invest Date: 2006-02-09 Impact factor: 14.808

5. Blockade of alpha4 integrin signaling ameliorates the metabolic consequences of high-fat diet-induced obesity.

Authors: Chloé C Féral; Jaap G Neels; Christiane Kummer; Marina Slepak; Jerrold M Olefsky; Mark H Ginsberg
Journal: Diabetes Date: 2008-04-21 Impact factor: 9.461

5 in total